REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinica La Dorada Ips S.A.S. Zomac (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Clinica La Dorada Ips S.A.S. Zomac Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Clinica La Dorada Ips S.A.S. Zomac is an enterprise based in Colombia. Its main office is in San Miguel. The enterprise currently operates in the Ambulatory Health Care Services sector. It was established on February 27, 2020. From the latest financial highlights, Clinica La Dorada Ips S.A.S. Zomac reported a net sales revenue increase of 338.98% in 2022. Its’ total assets recorded a growth of 17.02%. In, 2022, the company’s net profit margin decreased by 8.57%.

Headquarters
Brr Los Prados
San Miguel; Putumayo;

Contact Details: Purchase the Clinica La Dorada Ips S.A.S. Zomac report to view the information.

Basic Information
Outstanding Shares:
Purchase the Clinica La Dorada Ips S.A.S. Zomac report to view the information.
Incorporation Date:
February 27, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Clinica La Dorada Ips S.A.S. Zomac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
338.98%
Total operating revenue
338.98%
Operating profit (EBIT)
239.48%
Net Profit (Loss) for the Period
50.86%
Total assets
17.02%
Total equity
13.58%
Operating Profit Margin (ROS)
-4.91%
Net Profit Margin
-8.57%
Return on Equity (ROE)
2.96%
Quick Ratio
-3.8%
Cash Ratio
-3.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?